Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...
Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This Review presents a ...
Discover how advanced imaging technologies are uncovering the biological mechanisms behind breast cancer treatment resistance ...
The global protein chip market revenue was US$ 652.8 million in 2020. The global protein chip market is forecast to reach US$ 1,367.1 million by 2030, growing at a compound annual growth rate (CAGR) ...
Introduction: Head and neck cancer accounts for approximately 660,000 new cases annually worldwide and is increasing due to the consequences of interactions among environmental, socioeconomic and ...
1 Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China 2 China Department of Orthopedic, Fuzhou Second General Hospital, School of Clinical Medicine of Fujian Medical University, ...
Don’t Miss All the Twists and Turns! For exclusive news and updates, subscribe to our Dancing With the Stars Newsletter: Danielle Fishel hit the ballroom during the Dancing With the Stars premiere, ...
Abstract: The high dimensionality and complex structure of DNA microarray data pose significant challenges for accurate cancer detection, as redundant and irrelevant features may lead to overfitting ...
AZoLifeSciences on MSN
Microarray Profiling Identifies LINC00974 as a Sensitive Marker for Breast Cancer Risk
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results